Similar articles for PMID: 31818871

Year	Number of Results
2011	3
2012	6
2013	1
2014	4
2015	7
2016	12
2017	17
2018	16
2019	12
2020	5
2021	6
2022	2

1

Realizing the "40 by 2022" Commitment from the United Nations High-Level Meeting on the Fight to End Tuberculosis: What Will It Take to Meet Rapid Diagnostic Testing Needs?

Piatek AS, Wells WA, Shen KC, Colvin CE. Piatek AS, et al. Glob Health Sci Pract. 2019 Dec 23;7(4):551-563. doi: 10.9745/GHSP-D-19-00244. Print 2019 Dec 23. Glob Health Sci Pract. 2019. PMID: 31818871 Free PMC article.

2

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.

Wu Z, Rueda ZV, Li T, Zhang Z, Jiang Y, Sha W, Yu F, Chen J, Pan Q, Shen X, Yuan Z. Wu Z, et al. BMC Infect Dis. 2020 Feb 18;20(1):153. doi: 10.1186/s12879-020-4871-9. BMC Infect Dis. 2020. PMID: 32070292 Free PMC article.

3

Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.

Tesfaye A, Fiseha D, Assefa D, Klinkenberg E, Balanco S, Langley I. Tesfaye A, et al. BMC Infect Dis. 2017 May 2;17(1):318. doi: 10.1186/s12879-017-2417-6. BMC Infect Dis. 2017. PMID: 28464797 Free PMC article.

4

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

Trébucq A, Enarson DA, Chiang CY, Van Deun A, Harries AD, Boillot F, Detjen A, Fujiwara PI, Graham SM, Monedero I, Rusen ID, Rieder HL. Trébucq A, et al. Int J Tuberc Lung Dis. 2011 Dec;15(12):1567-72. doi: 10.5588/ijtld.11.0392. Epub 2011 Oct 13. Int J Tuberc Lung Dis. 2011. PMID: 22005110

5

Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens.

Habous M, E Elimam MA, Kumar R, L Deesi ZA. Habous M, et al. Int J Mycobacteriol. 2019 Apr-Jun;8(2):132-137. doi: 10.4103/ijmy.ijmy_83_19. Int J Mycobacteriol. 2019. PMID: 31210154 Free article.

6

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D. Chakravorty S, et al. mBio. 2017 Aug 29;8(4):e00812-17. doi: 10.1128/mBio.00812-17. mBio. 2017. PMID: 28851844 Free PMC article.

7

Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.

Kasa Tom S, Welch H, Kilalang C, Tefuarani N, Vince J, Lavu E, Johnson K, Magaye R, Duke T. Kasa Tom S, et al. Paediatr Int Child Health. 2018 May;38(2):97-105. doi: 10.1080/20469047.2017.1319898. Epub 2017 May 11. Paediatr Int Child Health. 2018. PMID: 28490246

8

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.

9

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K. Theron G, et al. Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14. Am J Respir Crit Care Med. 2011. PMID: 21493734

10

Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.

Langley I, Lin HH, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB. Langley I, et al. Lancet Glob Health. 2014 Oct;2(10):e581-91. doi: 10.1016/S2214-109X(14)70291-8. Lancet Glob Health. 2014. PMID: 25304634 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed